Poison Pill Increasingly A Tough Call
Weighing whether to adopt or extend a poison pill as part of a takeover defense strategy has become an increasingly complicated process for public companies, and recent pushes for corporate governance...To view the full article, register now.
Already a subscriber? Click here to view full article